Organism name | Amanita muscaria |
---|---|
Genus | Amanita |
Family | Amanitaceae |
Kingdom | Fungi |
Linked NCBI taxonomy name | Amanita muscaria |
---|---|
Linked NCBI taxonomy ID | 41956 |
Linked level | species |
Family in NCBI taxonomy | Amanitaceae |
---|---|
ID | 41954 |
Kingdom (Superkingdom) in NCBI taxonomy | Fungi |
---|---|
ID | 4751 |
Plant class | |
---|---|
ID |
Species | Activity |
---|---|
Amanita muscaria | GABA-Antagonist |
Amanita muscaria | Hallucinogen |
Amanita muscaria | Paralytic |
Amanita muscaria | Psychotropic |
Amanita muscaria | Stimulant |
Amanita muscaria | toxic |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001152
![]() |
Trehalose
|
D014199
|
No. 423 | No. 73 |
![]() |
|||
C00001602
![]() |
Muscapurpurin
|
No. 4567 | No. 71 |
![]() |
||||
C00001600
![]() |
Musca-aurin-II
|
No. 4567 | No. 71 |
![]() |
||||
C00027602
![]() |
(-)-allo-Muscarine
|
CHEMBL12587
CHEMBL105471 CHEMBL404094 CHEMBL1180201 |
12 / 8 / 5 | No. 5425 |
![]() |
|||
C00001422
![]() |
Muscarine
|
CHEMBL12587
CHEMBL105471 CHEMBL404094 CHEMBL1180201 |
D009116
|
12 / 8 / 5 | 0 / 1 | No. 5425 |
![]() |
|
C00001599
![]() |
Musca-aurin-I
|
No. 7057 | No. 71 |
![]() |
||||
C00001601
![]() |
Musca-aurin VII
|
No. 8118 | No. 71 |
![]() |
||||
C00001423
![]() |
Muscimol
|
CHEMBL273481
|
D009118
|
29 / 16 / 14 | 2 / 33 | No. 8889 |
![]() |
|
C00002345
![]() |
Ibotenic acid
|
CHEMBL284895
CHEMBL30285 |
D007051
|
19 / 18 / 23 | 0 / 7 | No. 8919 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001422 C00001423 C00002345 C00027602 | 1 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001422 C00001423 C00002345 C00027602 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001422 C00001423 C00002345 C00027602 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001422 C00001423 C00002345 C00027602 | 0 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001422 C00001423 C00002345 C00027602 | 0 / 1 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001422 C00001423 C00027602 | 3 / 2 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001422 C00027602 | 2 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001423 C00002345 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001422 C00027602 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00001423 C00002345 | 2 / 5 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001423 C00002345 | 0 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001422 C00027602 | 0 / 0 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001422 C00027602 | 1 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00001423 C00002345 | 1 / 2 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001422 C00027602 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001422 C00027602 | 0 / 0 |
P41594 | Metabotropic glutamate receptor 5 | Metabotropic glutamate receptor | C00002345 | 0 / 0 |
Q13255 | Metabotropic glutamate receptor 1 | Metabotropic glutamate receptor | C00002345 | 1 / 0 |
P28476 | Gamma-aminobutyric acid receptor subunit rho-2 | GABA-A rho | C00001423 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002345 | 0 / 0 |
Q14416 | Metabotropic glutamate receptor 2 | Metabotropic glutamate receptor | C00002345 | 0 / 0 |
P24046 | Gamma-aminobutyric acid receptor subunit rho-1 | GABA-A rho | C00001423 | 0 / 0 |
Q14833 | Metabotropic glutamate receptor 4 | Metabotropic glutamate receptor | C00002345 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002345 | 11 / 10 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001423 | 0 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00002345 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002345 | 0 / 0 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00002345 | 0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00002345 | 1 / 4 |
Q9UN88 | Gamma-aminobutyric acid receptor subunit theta | GABA-A theta | C00001423 | 0 / 0 |
P28472 | Gamma-aminobutyric acid receptor subunit beta-3 | GABA-A beta | C00001423 | 1 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | C00001423 | 1 / 1 |
P48169 | Gamma-aminobutyric acid receptor subunit alpha-4 | GABA-A alpha | C00001423 | 0 / 0 |
O14764 | Gamma-aminobutyric acid receptor subunit delta | GABA-A delta | C00001423 | 1 / 1 |
P31644 | Gamma-aminobutyric acid receptor subunit alpha-5 | GABA-A alpha | C00001423 | 0 / 0 |
Q99928 | Gamma-aminobutyric acid receptor subunit gamma-3 | GABA-A gamma | C00001423 | 0 / 0 |
P78334 | Gamma-aminobutyric acid receptor subunit epsilon | GABA-A epsilon | C00001423 | 0 / 0 |
Q8N1C3 | Gamma-aminobutyric acid receptor subunit gamma-1 | GABA-A gamma | C00001423 | 0 / 0 |
P34903 | Gamma-aminobutyric acid receptor subunit alpha-3 | GABA-A alpha | C00001423 | 0 / 0 |
O00591 | Gamma-aminobutyric acid receptor subunit pi | GABA-A pi | C00001423 | 0 / 0 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | C00001423 | 0 / 0 |
P18507 | Gamma-aminobutyric acid receptor subunit gamma-2 | GABA-A gamma | C00001423 | 4 / 2 |
P18505 | Gamma-aminobutyric acid receptor subunit beta-1 | GABA-A beta | C00001423 | 0 / 0 |
Q16445 | Gamma-aminobutyric acid receptor subunit alpha-6 | GABA-A alpha | C00001423 | 0 / 0 |
P47869 | Gamma-aminobutyric acid receptor subunit alpha-2 | GABA-A alpha | C00001423 | 1 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1138 | CHRNA5, LNCR2 | cholinergic receptor, nicotinic, alpha 5 (neuronal) |
C00001423
|
1140 | CHRNB1, ACHRB, CHRNB, CMS1D, CMS2A, SCCMS | cholinergic receptor, nicotinic, beta 1 (muscle) |
C00001423
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#103780 | Alcohol dependence |
P08172
P47869 |
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#607208 | Dravet syndrome |
P18507
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#607681 | Epilepsy, childhood absence, susceptibility to, 2; eca2 |
P18507
|
#612269 | Epilepsy, childhood absence, susceptibility to, 5; eca5 |
P28472
|
#613060 | Epilepsy, idiopathic generalized, susceptibility to, 10; eig10 |
O14764
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#604233 | Generalized epilepsy with febrile seizures plus, type 1; gefsp1 |
P18507
|
#611277 | Generalized epilepsy with febrile seizures plus, type 3; gefsp3 |
P18507
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#614831 | Spinocerebellar ataxia, autosomal recessive 13; scar13 |
Q13255
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00783 | Febrile seizures |
O14764
(related)
P18507 (related) |
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
P18507 (related) |
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000647 | Amnesia |
C00002345
C00001423 |
D019966 | Substance-Related Disorders |
C00001422
C00001423 |
D006948 | Hyperkinesis |
C00002345
C00001423 |
D006930 | Hyperalgesia |
C00001423
|
D001927 | Brain Diseases |
C00002345
|
D008569 | Memory Disorders |
C00002345
|
D009422 | Nervous System Diseases |
C00002345
|
D000544 | Alzheimer Disease |
C00002345
|
D001259 | Ataxia |
C00001423
|
D001289 | Attention Deficit Disorder with Hyperactivity |
C00001423
|
D001919 | Bradycardia |
C00001423
|
D002545 | Brain Ischemia |
C00001423
|
D002375 | Catalepsy |
C00001423
|
D002389 | Catatonia |
C00001423
|
D019970 | Cocaine-Related Disorders |
C00001423
|
D004195 | Disease Models, Animal |
C00001423
|
D004827 | Epilepsy |
C00001423
|
D020329 | Essential Tremor |
C00001423
|
D005334 | Fever |
C00001423
|
D001930 | Brain Injuries |
C00002345
|
D018476 | Hypokinesia |
C00001423
|
D007859 | Learning Disorders |
C00001423
|
D009123 | Muscle Hypotonia |
C00001423
|
D009127 | Muscle Rigidity |
C00001423
|
D009207 | Myoclonus |
C00001423
|
D009436 | Neural Tube Defects |
C00001423
|
D010146 | Pain |
C00001423
|
D020734 | Parkinsonian Disorders |
C00001423
|
D010409 | Penile Diseases |
C00001423
|
D049188 | Prenatal Injuries |
C00001423
|
D011605 | Psychoses, Substance-Induced |
C00001423
|
D012559 | Schizophrenia |
C00001423
|
D012640 | Seizures |
C00001423
|
D013226 | Status Epilepticus |
C00001423
|
D019956 | Stereotypic Movement Disorder |
C00001423
|
D013375 | Substance Withdrawal Syndrome |
C00001423
|
D013610 | Tachycardia |
C00001423
|
D053201 | Urinary Bladder, Overactive |
C00001423
|